Evidence map›Paper›PMID 40430061›Full record

Trial reportInternational journal of molecular sciences2025

Rapid Reduction of Pro-Inflammatory Cytokines with an Oral Topical Composition Comprising Olive Oil, Trimethylglycine and Xylitol: A Randomized Double-Blind Controlled Trial.

José López-López, José M Reuss, Teresa Vinuesa-Aumedes, Sonia Egido-Moreno, Xavier Roselló-Llabres, Tanya Pereira-Riveros, Debora Reuss, Laura Alonso-Gamo, Beatriz Rodríguez-Vilaboa

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

José López-LópezDepartment of Odontostomatology, Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona, 08907 Barcelona, Spain.ORCID 0000-0001-8035-4412
José M ReussDepartment of Postgraduate Prosthodontics, Faculty of Dentistry, Complutense University of Madrid, 28040 Madrid, Spain.
Teresa Vinuesa-AumedesUnit of Microbiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, University of Barcelona, 08907 Barcelona, Spain.ORCID 0000-0002-3536-4109
Sonia Egido-MorenoDepartment of Odontostomatology, Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona, 08907 Barcelona, Spain.
Xavier Roselló-LlabresDepartment of Odontostomatology, Faculty of Medicine and Health Sciences (Dentistry), University of Barcelona, 08907 Barcelona, Spain.
Tanya Pereira-RiverosUnit of Microbiology, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, University of Barcelona, 08907 Barcelona, Spain.ORCID 0009-0000-5899-6320
Debora ReussDepartment of Odontostomatology, Faculty of Medicine, San Pablo CEU University, 28668 Madrid, Spain.
Laura Alonso-GamoDepartment of Endocrinology, Paediatrics Unit, University Hospital Quirón Madrid-European University, 28223 Madrid, Spain.
Beatriz Rodríguez-VilaboaDepartment of Odontostomatology, Faculty of Medicine, San Pablo CEU University, 28668 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An underlying pro-inflammatory status is related to recurrence and persistence of inflammatory susceptibility in obesity and periodontitis, two of the most prevalent chronic inflammatory diseases. Elevated levels of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), part of the inflammatory network linking these two conditions, persist even after periodontal treatment, with high salivary cytokine levels being linked to overweight and obesity risk. This trial assessed the effect of a novel composition comprising olive oil, trimethylglycine and xylitol, delivered topically to the oral mucosa, on salivary cytokines in periodontally healthy normal and overweight/pre-obese individuals. In a randomized placebo-controlled double-blind clinical trial, adult patients were randomly assigned to use a test toothpaste (intervention group, IG) or a placebo toothpaste (control group, CG) three times a day for 1 month. Primary outcomes were levels of salivary cytokines IL-1β, TNF-α and interleukin-4 (IL-4). Significant differences between IG and CG were observed for IL-1β (

Indexed as

CytokinesGlycineOlive OilXylitolAdultDouble-Blind MethodFemaleHumansInterleukin-1betaInterleukin-4MaleMiddle AgedObesityOverweightSalivaTumor Necrosis Factor-alphaCytokinesGlycineIL1B protein, humanInterleukin-1betaInterleukin-4Olive OilTumor Necrosis Factor-alphaXylitolchronic inflammatory diseasescytokinesIL-1βinflammationmicrobiome dysbiosismucosa barrier disruptionobesityolive oil, trimethylglycine and xylitoloverweightTNF-α

Identifiers

PMID40430061
PMCPMC12112298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.